Nursing research : reading, using, and creating evidence / per Houser, Janet, 1954-

Clinical trial designs for rare diseases part 2 of 2, trial protocols /

Obtenir text complet

Randomization, blinding and drug supply in interactive voice response trials

Obtenir text complet
Series

Phase II clinical trials traditional approaches /

Obtenir text complet
Series

Phase II clinical trials Bayesian methods /

Obtenir text complet
Series

Patient heterogeneity in dose-finding trials part 1, methods for 2 groups/

Obtenir text complet
Series

Patient heterogeneity in dose-finding trials part 2, more than 2 groups /

Obtenir text complet
Series

Analysis of LCMS-based untargeted metabolomics data part 2 of 2 /

Obtenir text complet
Series

Implementation of adaptive methods in early phase clinical trials

Obtenir text complet
Series

Metabolomics importance of experimental design to data acquisition, part 1 of 2 /

Obtenir text complet
Series

Design and conduct of non-inferiority trials

Obtenir text complet
Series (Risk of bias in randomized clinical trials)
Series (Design and analysis of randomized clinical trials)

Metabolomics importance of experimental design to data acquisition, part 2 of 2 /

Obtenir text complet
Series

Adaptation in likelihood trials

Obtenir text complet
Series

The Salford lung study in COPD

Obtenir text complet
Series

Univariate statistics and metabolomics

Obtenir text complet
Series

Adaptive clinical trial design randomization /

Obtenir text complet
Series

Clinical research and care in the era of "N-of-1" precision cancer medicine

Obtenir text complet
Series

Frequentist approaches sample size in adaptive clinical designs /

Obtenir text complet
Series

Adaptive clinical trials overview, part 1 of 2 /

Obtenir text complet
Series

Adaptive clinical trials conclusion and future directions /

Obtenir text complet
Series